SCHEMBL24257905

SCHEMBL24257905

CCCCCc1ccc(CCOc2ccc(S(=O)(=O)Nc3ncc(C(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)O)cn3)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
RAB9A P51151 2/20 0.42
SMN1; SMN2 Q16637 7/20 0.41
PKM P14618 1/20 0.41
MAPT P10636 2/20 0.40
TP53 P04637 1/20 0.40
RXFP1 Q9HBX9 1/20 0.39
AKT1 P31749 1/20 0.39
IRS1 P35568 1/20 0.39
GAB1 Q13480 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
TSHR P16473 2/20 0.38
RECQL P46063 1/20 0.38
LMNA P02545 2/20 0.38
CYP3A4 P08684 2/20 0.38
USP2 O75604 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPK1 P28482 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24257940 0.95 AKT1 (0.42) MEN1KMT2ASMN1; SMN2PKMAKT1
SCHEMBL24257854 0.95 SMN1; SMN2 (0.41) NPC1MEN1KMT2ARAB9ASMN1; SMN2
SCHEMBL24257935 0.95 SMN1; SMN2 (0.40) NPC1MEN1KMT2ARAB9ASMN1; SMN2
SCHEMBL24257934 0.93 KDM4E (0.44) NPC1MEN1KMT2ARAB9ASMN1; SMN2
SCHEMBL22080442 0.92 SMN1; SMN2 (0.39) NPC1MEN1KMT2ARAB9ASMN1; SMN2
SCHEMBL24257961 0.92 SMN1; SMN2 (0.39) NPC1MEN1KMT2ARAB9ASMN1; SMN2
SCHEMBL22079911 0.92 ALDH1A1 (0.38) NPC1MEN1KMT2ARAB9ASMN1; SMN2
SCHEMBL24257844 0.92 HDAC3 (0.43) NPC1MEN1KMT2ARAB9ASMN1; SMN2
SCHEMBL31682008 0.89 SMN1; SMN2 (0.37) MEN1KMT2ASMN1; SMN2PKMTDP1
SCHEMBL22080214 0.88 SMN1; SMN2 (0.37) MEN1KMT2ASMN1; SMN2PKMTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220048968-A1 INSULIN CONJUGATES SANOFI (FR) 2022-02-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220048968-A1 INSULIN CONJUGATES IAPP, INSR, IGF1R NPC1 3240/4885MEN1 40/4885KMT2A 953/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.